You have 9 free searches left this month | for more free features.

IPSS-R very low/IPSS-R low/IPSS-R intermediate

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelodysplastic Syndrome (MDS) Trial in United States (MBG453, Azacitidine, Decitabine)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • Chandler, Arizona
  • +22 more
Dec 5, 2022

Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)

Active, not recruiting
  • Myelodysplastic Syndrome
  • Strasbourg, Bajo Rin, France
  • +24 more
Nov 22, 2021

Lymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Intermediate-Grade Trial in Munich (procedure, drug, other)

Active, not recruiting
  • Lymphoma, Follicular
  • +2 more
  • FCM
  • +3 more
  • Munich, Germany
    German Low Grade Study Group (Glsg)
May 6, 2021

Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

Terminated
  • Myelodysplastic Syndrome
  • +3 more
  • La Jolla, California
  • +157 more
Sep 22, 2022

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +168 more
Dec 7, 2022

REVLIMID® Treatment of IPSS Low- or Intermediate-1-risk

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Anyang, Korea, Republic of
  • +12 more
Apr 6, 2021

Prostate Cancer Stage I Trial in Torino (Katty focal therapy)

Completed
  • Prostate Cancer Stage I
  • Katty focal therapy
  • Torino, TO, Italy
    A.O.U. San Giovanni Battista Molinette
Jan 31, 2023

Anemia Trial in United States (Drawing admission labs from cord blood, Drawing admission labs from infant blood)

Completed
  • Anemia
  • Drawing admission labs from cord blood
  • Drawing admission labs from infant blood
  • Honolulu, Hawaii
  • +5 more
Aug 18, 2021

Very Low Birth Weight Infant Trial in Canada (Standard fortification, Target fortification, BUN adjustable fortification)

Recruiting
  • Very Low Birth Weight Infant
  • Standard fortification
  • +2 more
  • Edmonton, Alberta, Canada
  • +19 more
Apr 1, 2022

Myelodysplastic Syndrome Trial in Worldwide (Lenalidomide)

Completed
  • Myelodysplastic Syndrome
  • Centre City, New Jersey
  • +148 more
Aug 18, 2022

MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Luspatercept Injection [Reblozyl]
  • Alessandria, Italy
  • +22 more
Jun 20, 2023

Very Low Birth Weight Infant (<1250g) Trial in Canada (Human milk-based fortifier, Bovine protein-based fortifier)

Completed
  • Very Low Birth Weight Infant (<1250g)
  • Human milk-based fortifier
  • Bovine protein-based fortifier
  • Halifax, Nova Scotia, Canada
  • +17 more
Nov 23, 2021

MDS (MDS) Trial in United States (Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine)

Completed
  • Myelodysplastic Syndromes (MDS)
  • Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine
  • Chicago, Illinois
  • +11 more
Apr 4, 2022

Non-specific Low Back Pain Trial (Multimodal Exercises and Education delivered through tele rehabilitation, Selafcare)

Not yet recruiting
  • Non-specific Low Back Pain
  • Multimodal Exercises and Education delivered through tele rehabilitation
  • Selafcare
  • (no location specified)
Oct 15, 2023

Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,

Recruiting
  • Aplastic Anemia
  • +3 more
  • Anti-Thymocyte Globulin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2021

Urinary Tract Infection Trial in Taichung (Nettle and Cranberry complex capsules, Placebo(starch))

Not yet recruiting
  • Urinary Tract Infection
  • Nettle and Cranberry complex capsules
  • Placebo(starch)
  • Taichung, Taiwan
    Chung Shan Medical University Hospital
May 19, 2023

Philadelphia Negative Myeloproliferative Tumors Trial

Not yet recruiting
  • Philadelphia Negative Myeloproliferative Neoplasms
    • (no location specified)
    Jun 5, 2022

    Myelodysplastic Syndrome (MDS) Trial (FF-10501-01, Azacitidine)

    Withdrawn
    • Myelodysplastic Syndrome (MDS)
    • (no location specified)
    Jul 20, 2021

    Prostate Cancer Trial in Québec (Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant, Stereotactic Body

    Recruiting
    • Prostate Cancer
    • Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant
    • Stereotactic Body Radiation Therapy to the prostate
    • Québec, Canada
      Centre Intégré de Cancérologie, CHU de Québec-Université Laval
    Sep 21, 2023

    MDS Trial (Hetrombopag)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • (no location specified)
    May 23, 2022

    ACL Injury, ACL Sprain, ACL Tear Trial (Isoinertial training, Strength Training)

    Not yet recruiting
    • ACL Injury
    • +4 more
    • Isoinertial training
    • Strength Training
    • (no location specified)
    Sep 25, 2023

    MDS Patients Using Sequential Peripheral Blood Samples

    Recruiting
    • Myelodysplastic Syndromes
      • Badalona, Barcelona, Spain
        Josep Carreras Leukaemia Research Institute
      Mar 8, 2022

      Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

      Recruiting
      • Leukemia, Myeloid, Acute
      • +2 more
      • H3B-8800 (RVT-2001)
      • Stanford, California
      • +26 more
      Mar 23, 2022